A new CBD capsule, which has clinically proven bioavailability, provides a reliable dose and is GMP manufactured, is now nationally available in pharmacy in Ireland.
The new CBD capsule comes from Satipharm, a health and wellness company specialising in the development and manufacture of cannabinoid-based products from the cannabis and hemp plants.
Satipharm CBD Gelpell® capsules deliver a consistent 10mg dose of CBD each time a capsule is taken. The capsule contains Satipharm’s advanced Gelpell® technology, which places CBD into seamless micro-beads. These Gelpell® beads provide a clinically proven level of bioavailability* which is over three times higher than that of standard CBD oils, representing a significant advancement over the current CBD oils and capsules found on shelves in many stores today.
Satipharm CBD Gelpell® capsules are manufactured under Good Manufacturing Practice (GMP). The GMP certification ensures the highest quality and safety standards.
Jonathan Hartshorn, CEO Satipharm Ireland, said: “Our goal at Satipharm is to provide CBD and other cannabinoids in the best possible formats and, importantly, to educate pharmacists, counter staff and consumers in the proven benefits of Satipharm products.
“Placing CBD into our proprietary Gelpell® technology ensures over three times more CBD reaches the body than the same dose of CBD oil.”
Satipharm is now available in pharmacy and Holland & Barrett stores nationwide. For more information visit satipharm.com.
